Skip to content

Clinical trials

Lymphadenopathy trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphadenopathy Country / region: United States Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20031
20041
20081
20092
20101
20111
20124
20132
20153
20162
20171
20182
20201
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed18
Active, not recruiting4
Terminated2
Unknown status1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center4
National Institute of Allergy and Infectious Diseases (NIAID)3
City of Hope Medical Center2
Emory University1
HealthPartners Institute1
Johns Hopkins University1
Koneti Rao1
Light Sciences LLC1
Massachusetts General Hospital1
Mauna Kea Technologies1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphadenopathy26
Leukemia, Lymphocytic, Chronic, B-Cell4
Lymphoproliferative Disorders4
Pancreatic Neoplasms4
Splenomegaly4
Autoimmune Lymphoproliferative Syndrome3
Fever3
Lymphocytosis3
Neoplasms3
Thrombocytopenia3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.